Liu Dongfang, Chief Medical Officer at Nuvation Bio Inc. ($NUVB), made seven open market sales of company shares over the last 365 days, totaling $1.67 million. His most recent sale occurred on December 1, 2025. These sales rank 3,844th among 11,678 individual insiders in our database, where the average sale value is $8.59 million across 6.37 transactions. Liu Dongfang recorded no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 748130 | $0.00 | 748,130.0000 | 342,833,433 | 9999.99% | 0.22% |
| Dec. 1, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 150000 | $0.00 | 165,000.0000 | 342,833,433 | 47.62% | 0.04% |
| Dec. 1, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | S | Class A Common Stock | 150000 | $7.82 | 18,000.0000 | 342,833,433 | 89.29% | 0.04% |
| Dec. 1, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Class A Common Stock | 150000 | $2.93 | 168,000.0000 | 342,833,433 | 833.33% | 0.04% |
| Nov. 26, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Class A Common Stock | 10000 | $3.61 | 28,000.0000 | 342,833,433 | 55.56% | 0.00% |
| Nov. 25, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Class A Common Stock | 10000 | $3.61 | 28,000.0000 | 342,833,433 | 55.56% | 0.00% |
| Nov. 25, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | S | Class A Common Stock | 10000 | $7.50 | 18,000.0000 | 342,833,433 | 35.71% | 0.00% |
| Nov. 26, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 470,000.0000 | 342,833,433 | 2.08% | 0.00% |
| Nov. 25, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 10000 | $0.00 | 480,000.0000 | 342,833,433 | 2.04% | 0.00% |
| Nov. 26, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | S | Class A Common Stock | 10000 | $8.00 | 18,000.0000 | 342,833,433 | 35.71% | 0.00% |
| Nov. 20, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | S | Class A Common Stock | 20000 | $7.00 | 18,000.0000 | 342,833,433 | 52.63% | 0.01% |
| Nov. 20, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Class A Common Stock | 20000 | $1.87 | 38,000.0000 | 342,833,433 | 111.11% | 0.01% |
| Nov. 20, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 20000 | $0.00 | 450,000.0000 | 342,833,433 | 4.26% | 0.01% |
| Nov. 17, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Class A Common Stock | 15000 | $1.87 | 30,000.0000 | 342,833,433 | 100.00% | 0.00% |
| Nov. 19, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 15000 | $0.00 | 470,000.0000 | 342,833,433 | 3.09% | 0.00% |
| Nov. 17, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 15000 | $0.00 | 485,000.0000 | 342,833,433 | 3.00% | 0.00% |
| Nov. 19, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | S | Class A Common Stock | 15000 | $5.10 | 18,000.0000 | 342,833,433 | 45.45% | 0.00% |
| Nov. 19, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Class A Common Stock | 15000 | $1.87 | 30,000.0000 | 342,833,433 | 100.00% | 0.00% |
| Nov. 17, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | S | Class A Common Stock | 15000 | $4.77 | 15,000.0000 | 342,833,433 | 50.00% | 0.00% |
| May 2, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Class A Common Stock | 20000 | $1.94 | 32,000.0000 | 337,678,855 | 166.67% | 0.01% |
| May 2, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | M | Stock Option (Right to Buy) | 20000 | $1.94 | 480,000.0000 | 337,678,855 | 4.00% | 0.01% |
| May 2, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | S | Class A Common Stock | 20000 | $2.50 | 12,000.0000 | 337,678,855 | 62.50% | 0.01% |
| Feb. 28, 2025 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 29, 2024 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | CHIEF MEDICAL OFFICER | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 28, 2023 | Nuvation Bio Inc. | $NUVB | Liu Dongfang | Chief Medical Officer | A | Stock Option (Right to Buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |